Singapore #3793 (v.2)
Base data
- Notified in
- Version validity
-
01/10/2014 -
01/10/2020
Old version v.2
- Reporting member
- Singapore
- In force from
- End date
- In force
- General description
-
Non-automatic licence for the import of Cell and Tissue Therapy Products and Chinese proprietary medicines
- National legal basis
-
Medicines Act; 1975
- Administrative mechanism
-
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016; cell and tissue –based products and CPMs will continue to be regulated under the Medicines Act for now.More info. can be found at at: http://www.hsa.gov.sg/content/hsa/en.html. Administered by HSA
- Responsible entities
-
Health Sciences Authority
- HS version
-
HS 2012
- Referenced WTO document symbol
-
Meta data
- WTO justifications
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Reported as: Article XX(b) of the GATT - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- NAL
| Symbol |
|---|
|
NAL
|
Tariff lines
|
|
Various
|
https://www.tradexchange.gov.sg/tradexchange/ShowBinary/BEA%20Repository/txwp/document/app_p20140602...
|
|